Osborne Clarke has advised activpayroll Ltd. on the deal. activpayroll, a leading provider of global payroll and HR solutions, has completed the acquisition of LIMES International (‘LIMES’),...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised QinetiQ on the deal. QinetiQ has sold QinetiQ Space NV, a Belgium-based commercial space business providing design and integration of critical space infrastructure...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Bone Therapeutics on the deal. Bone Therapeutics acquired a majority stake in Medsenic. This combination of Bone Therapeutics and Medsenic has created...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Wallenius Wilhemsen on the deal. Wallenius Wilhemsen acquired ALS. ALS is well known for delivering innovative logistics solutions for oversized, exceptional, and heavy...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Atradius Insurance Holding N.V. on the deal. Atradius Insurance Holding N.V. sold Graydon Holding N.V. to Creditsafe Nederland BV (part of Creditsafe...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Dutch farming cooperative, Royal Agrifirm Group on the deal. Royal Agrifirm Group signed a five-year unsecured €200,000,000 revolving credit facility arranged by ING...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Interel on the deal. Interel, an award-winning pan-European public affairs consultancy, has been acquired by Dentons Global Advisors. Interel has offices in...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised the Brokker Group on the deal. The Brokker Group acquired Pillaert Meststoffen NV, a leading wholesaler of mineral fertilisers and related products based...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Bone Therapeutics on the deal. Bone Therapeutics, the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, received...
You must be a Standard 1 Year member to access this content.
